Project Details
Description
A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 As Adjuvant Therapy In Subjects with High Risk HER2+ Urothelial Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 3/3/11 → 12/31/20 |
Funding
- DENDREON CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.